- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05810259
Assessing the Effectiveness of Digital Wellness Modules on Perceived Quality of Life
Assessing the Effectiveness of Digital Wellness Modules on Perceived Quality of Life Via a Randomized Control Trial
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Primary Objective: The primary objective of this parallel-assignment longitudinal study is to determine whether the digital wellness modules (e.g., mindfulness and light to moderate physical activity) increase quality of life and decrease stress, anxiety, and depression, as mediated by health behavior motivation and change in a healthy population of adults. Secondary Objective(s): The secondary objective is to ascertain qualitatively through deductive thematic analysis specific themes of a) key drivers of health behavior change; b) types of motivations that drive health behavior change, and c) implementation of sustained health behavior change.
The study will be conducted virtually by Yale University researchers.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: David Klemanski, Psy.D., MPH
- Phone Number: 203.214.5426
- Email: david.klemanski@yale.edu
Study Locations
-
-
Connecticut
-
New Haven, Connecticut, United States, 06520
- Yale University
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Resides in United States
Exclusion Criteria:
- Any individual who endorses any of the following criteria will be excluded from participation in this study:
Positive Health Screening Questions, as measured by the Health Screening Questionnaire (HSQ):
- Pain, discomfort or pressure in the chest, difficulty breathing or shortness of breath, dizziness, fainting, or blackout, blood pressure with systolic greater than 140 or diastolic greater than 90, diagnosed or treated for any heart disease, heart murmur, chest pain (angina), palpitations (irregular beat), or heart attack, heart surgery, angioplasty, or a pacemaker, valve replacement, or heart transplant, resting pulse greater than 100 beats per minute, any arthritis, back trouble, hip /knee/joint /pain, or any other bone or joint condition, personal experience or doctor's advice of any other medical or physical reason that would prohibit the participant from doing light to moderate physical exercise, personal physician's recommendation against participating in light to moderate physical exercise because of asthma, diabetes, epilepsy or elevated cholesterol or a hernia.
Positive Psychiatric Disorders Screening Questions:
- Positive screen for depression, excluding suicide (PHQ-8) cutoff score > 6
- Positive screen for panic (SMPD) cutoff score > 2
- Positive screen for generalized anxiety (GAD-7) cutoff score > 10
- Positive screen psychosis (PDSQ) via psychosis section, cutoff score > 3
- Positive screen mania via the Altman Self-Rating Mania Scale (ASRM) cutoff score > 6
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Mindfulness
Participants will take part in 7 repeating digital mindfulness modules using the Caravan Wellness App.
|
Caravan Wellness is a digital platform that offers brief mindfulness and light to moderate physical activity modules, among many others (e.g., Pilates, Yoga, Barre, meditation, etc.), to enhance overall individual well-being.
|
Experimental: Light to Moderate Physical Activity
Participants will take part in 7 repeating light to moderate physical activity digital wellness modules using the Caravan Wellness App.
|
Caravan Wellness is a digital platform that offers brief mindfulness and light to moderate physical activity modules, among many others (e.g., Pilates, Yoga, Barre, meditation, etc.), to enhance overall individual well-being.
|
No Intervention: Control
A no intervention group that will not be using the Caravan Wellness App.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in Mindfulness assessed by the Five Facet Mindfulness Questionnaire (FFMQ)
Time Frame: baseline, 1 Month follow up, 3 Month follow up
|
The FFMQ is a 39-item questionnaire created to further explore the facet structure of mindfulness in daily life as a construct.
It is composed of five component skills which contribute to mindfulness, non-reactivity to inner experiences (7 items), observing (8 items), acting with awareness (8 items), non-judging of inner experiences (8 items), and describing (8 items).
Items are rated on a 5-point Likert- type scale, ranging from 1 (never or very rarely true) to 5 (very often or always true).
Higher scores indicate more mindfulness.
|
baseline, 1 Month follow up, 3 Month follow up
|
Change in Exercise Behavior assessed by the Behavior Regulation Exercise Questionnaire, Third Version (BREQ-3)
Time Frame: baseline, 1 Month follow up, 3 Month follow up
|
The BREQ-3 is a 24-item scale with five factors that measure external, introjected, identified, and intrinsic forms of regulation of exercise behavior based on Deci & Ryan's continuum conception of extrinsic and intrinsic motivation, described by organismic integration theory.
Each item is scored on a five-point Likert scale, ranging from 0 ("Strongly Disagree") to 4 ("Strongly Agree").
Higher scores indicate an increase in exercise.
|
baseline, 1 Month follow up, 3 Month follow up
|
Utility of the Modules assessed by self report
Time Frame: up to Day 22
|
Perceived utility of the modules will be assessed by self report using a one-item 5-point Likert scale = 0 (strongly disagree), 1 (disagree), 2 (agree), 3 (strongly agree), or 4 (undecided).
|
up to Day 22
|
Daily stressors assessed using the Brief Daily Stressors Screening Tool (BDSST)
Time Frame: up to Day 22
|
Daily stressors will be assessed using the BDSST, a short instrument for the recording of perceived general daily stressors in eight different areas of life.
It is particularly suitable for use in large-scale studies or as a screening instrument for localizing areas of life where stress is particularly prevalent.
A five-point Likert scale is used to measure the extent of the perceived stress experience from 0 ("Not at all") to 4 ("Very much") The higher the score, the more pronounced the subjective experience of general everyday stress.
|
up to Day 22
|
Average number of minutes spent on Intervention
Time Frame: up to Day 22
|
The average number of minutes per day spent on Intervention, as measured by self-report.
|
up to Day 22
|
Change in health behavior motivation assessed using the Health Behavior Motivation Scale (HBMS)
Time Frame: baseline, 1 Month follow up, 3 Month follow up
|
Change in health behavior motivation will be measured using the HBMS, a 30-item, five-point Likert scale that has a five-dimensional structure (i.e., intrinsic regulation, integrated and identified regulation, introjected regulation, external regulation, and amotivation).
Scale ranges from 1 ("Definitely disagree") to 5 ("Definitely agree").
Higher scores indicate more health behavior motivation.
|
baseline, 1 Month follow up, 3 Month follow up
|
CHange in health behavior assessed using he Health Behavior Inventory-20 (HBI-20).
Time Frame: baseline, 1 Month follow up, 3 Month follow up
|
Health behavior change will be measured using the HBI-20.
The measure consists of a 20-items that factor into five subscales.
Three subscales reflect health-promoting behaviors: Diet (five items), Preventive Care (seven items), and Medical Compliance (two items), and two subscales reflect health risk behaviors: Anger and Stress (three items), and Substance Use (three items).
The health risk items are reverse-scored so that high scores on all subscales indicate a greater degree of health promotion and risk avoidance.
Respondents are asked to rate the extent to which each item was self-descriptive, using a 7-point scale (e.g., 1 = always through 7 =never).
Subscale scores are obtained by summing participants' responses (after reverse coding the risk items) and dividing them by the number of items.
|
baseline, 1 Month follow up, 3 Month follow up
|
Quality of life assessed using the Quality of Life Inventory (QOLI)
Time Frame: baseline, 1 Month follow up, 3 Month follow up
|
The QOLI has 16 well-defined domains: health, self-esteem, goals and values, money, work, play, learning, creativity, helping, love, friends, children, relatives, home, neighborhood, and community.
Within each domain, respondents are asked to rate the importance of that domain to their happiness on a 3-point scale: 0 = Not important, 1 = Important, and 2 = Extremely important.
They then rate their satisfaction with each domain from -3 = Extremely, -2 = Somewhat, and -1 = A little dissatisfied to +1 = A little, +2 = Somewhat, and +3 = Extremely satisfied for each domain.
The QOLI is scored by multiplying importance scores by satisfaction scores for each of the 16 domains, and then calculating an average across domains.
|
baseline, 1 Month follow up, 3 Month follow up
|
Change in stress and non-pathological anxiety and depression assessed using the Depression, Anxiety, and Stress Scale (DASS-21)
Time Frame: baseline, 1 Month follow up, 3 Month follow up
|
The DASS-21 assesses key symptoms of depression, anxiety, and stress.The 21 items on the questionnaire comprise a set of three scales designed to assess depression, anxiety, and stress.
The seven elements on each scale are rated on a Likert scale from 0 to 3 (0: "Did not apply to me at all," 1: "Applied to me to some degree or some of the time," 2: "Applied to me to a considerable degree or a good part of the time," and 3: "Applied to me very much or most of the time").
Scale scores are measured by summarizing the scores of the related items and then multiplying them by 2 to calculate the final score.
Resulting ratings are then classified as: Depression: normal (0-4), mild (5-6), moderate (7-10), severe (11-13), or extremely severe (14+); Anxiety: normal (0-3), mild (4-5), moderate (6-7), severe (8-9), extremely severe (10+); Stress: normal (0-7), mild (8-9), moderate (10-12), severe (13-16), extremely severe (17+).
|
baseline, 1 Month follow up, 3 Month follow up
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Sleep quality assessed using the Pittsburgh Sleep Quality Index (PSQI)
Time Frame: baseline, 1 Month follow up, 3 Month follow up
|
The PSQI is designed to evaluate overall sleep quality in clinical and non-clinical populations.
The measure includes 19 self-reported items belonging to one of seven subcategories, including subjective sleep quality, sleep latency, sleep duration, habitual sleep efficiency, sleep disturbances, use of sleeping medication, and daytime dysfunction.
The questionnaire consists of a combination of Likert- type and openended questions (later converted to scaled scores using provided guidelines).
Respondents are asked to indicate how frequently they have experienced certain sleep difficulties over the past month and to rate their overall sleep quality.
Scores for each question range from 0 to 3, with higher scores indicating more acute sleep disturbances.
|
baseline, 1 Month follow up, 3 Month follow up
|
Physical activity assessed using the International Physical Activity Questionnaire, Long Form (IPAQ-LF).
Time Frame: up to Day 22
|
The IPAQ-LF is a 27-item survey that assesses the types of intensity of physical activity and sitting time.
The scale asks respondents to rate during the last seven days engagement with physical activities.
|
up to Day 22
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: David Klemanski, Psy.D., MPH, Yale University
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- 2000034914
- 000 (Other Identifier: CTGTY)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Depression
-
ProgenaBiomeRecruitingDepression | Depression, Postpartum | Depression, Anxiety | Depression Moderate | Depression Severe | Clinical Depression | Depression in Remission | Depression, Endogenous | Depression ChronicUnited States
-
Washington University School of MedicineCompletedTreatment Resistant Depression | Late Life Depression | Geriatric Depression | Refractory Depression | Therapy-Resistant DepressionUnited States, Canada
-
Kintsugi Mindful Wellness, Inc.Sonar Strategies; Vituity PsychiatryRecruitingDepression | Depression Moderate | Depression Severe | Depression MildUnited States
-
University of California, San FranciscoRecruitingDepression Moderate | Depression Mild | Depression, TeenUnited States
-
University GhentUniversiteit Antwerpen; Janssen-Cilag Ltd.RecruitingDepression Moderate | Depression Severe | Depression MildBelgium
-
Baylor College of MedicineUniversity of TexasRecruitingDepression | Depression Moderate | Depression Severe | Suicide and Self-harm | Depression in Adolescence | Depression MildUnited States
-
University of Cape TownNational Institute of Mental Health (NIMH)CompletedPostpartum Depression | Clinical Depression | Moderate DepressionSouth Africa
-
Washington University School of MedicinePatient-Centered Outcomes Research Institute; National Institute of Mental...CompletedMajor Depressive Disorder | Treatment Resistant Depression | Treatment-Refractory Depression | Late Life Depression | Geriatric DepressionUnited States, Canada
-
Northern Illinois UniversityUniversity Autonoma de Santo DomingoTerminatedDepression Moderate | Depression MildUnited States, Dominican Republic
-
Gerbera Therapeutics, Inc.Not yet recruitingPostpartum Depression | Depression, Postpartum | Postnatal Depression | Post-partum Depression | Post-Natal DepressionUnited States
Clinical Trials on Caravan Wellness app
-
The University of Texas Health Science Center at...National Cancer Institute (NCI); Wake Forest University Health Sciences; Arizona... and other collaboratorsRecruitingDepression | Inflammation | Cancer | Fatigue | Anxiety | Sleep DisturbanceUnited States
-
University of MichiganCompletedMental Health IssueUnited States
-
Massachusetts General HospitalActive, not recruiting
-
Case Comprehensive Cancer CenterCompletedStage IV Gastrointestinal Cancer | Advanced Gynecological CancerUnited States
-
Evidence-Based Practice Institute, Seattle, WANot yet recruitingAlcoholism | Suicidal Ideation | Suicide, Attempted | Suicide | Alcohol Use Disorder | Alcohol Abuse | Screening and Brief InterventionsUnited States
-
Bournemouth UniversityRoyal Bournemouth and Christchurch Hospitals NHS Foundation Trust; Oomph! Wellness and other collaboratorsWithdrawnFrail Elderly Syndrome | Frailty | Sedentary Behavior | Life Style Induced Illness | Lifestyle, Sedentary
-
University of Texas at AustinCompleted
-
University of Texas at AustinCompletedHealthy | Chronic Pain | Stress, PsychologicalUnited States
-
University of Texas at AustinCompletedHealthy | Rheumatoid Arthritis | Chronic Pain | Stress | PsychologicalUnited States
-
Federal University of São PauloFundação de Amparo à Pesquisa do Estado de São PauloCompletedObesity | SchizophreniaBrazil